Trials / Terminated
TerminatedNCT00094666
Elderly Primary Insomnia Polysomnographic Study (0928-002)(TERMINATED)
A Double-Blind, Randomized, Placebo-Controlled, Multicenter, 30-Night Polysomnographic Study of MK0928 in Elderly Patients With Primary Insomnia
- Status
- Terminated
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 465 (planned)
- Sponsor
- H. Lundbeck A/S · Industry
- Sex
- All
- Age
- 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to test the safety and effectiveness of an Investigational Drug on insomnia in the elderly.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MK0928, gaboxadol / Duration of Treatment - 6 weeks | |
| DRUG | Comparator: placebo / Duration of Treatment - 6 weeks |
Timeline
- Start date
- 2004-11-01
- Primary completion
- 2007-03-01
- Completion
- 2007-03-01
- First posted
- 2004-10-22
- Last updated
- 2015-01-14
Source: ClinicalTrials.gov record NCT00094666. Inclusion in this directory is not an endorsement.